Suppression of thymus- and activation-regulated chemokine (TARC/CCL17) production by 1,2,3,4,6-penta-O-galloyl-β-d-glucose via blockade of NF-κB and STAT1 activation in the HaCaT cells

Biochemical and Biophysical Research Communications

Volumn 387, Issue 1, 2009, Pages 115-120

  Ju, Sung Mi ^a   Song, Ha Yong ^a   Lee, Su Jin ^a   Seo, Won Yong ^a   Sin, Dong Hyeon ^a   Goh, Ah Ra ^a   Kang, Young Hee ^a   Kang, Il Joon ^a   Won, Moo Ho ^a   Yi, Jae Seon ^b   Kwon, Dong Joo ^b   Bae, Young Soo ^b   Choi, Soo Young ^a   Park, Jinseu ^a  

^a Hallym University   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

CCL17; Inflammation; Keratinocyte; NF B; PGG; STAT1; TARC

Indexed keywords

4 (2 AMINOETHYLAMINO) 1,8 DIMETHYLIMIDAZO[1,2 A]QUINOXALINE; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCOSE PENTAGALLATE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE INHIBITOR; MESSENGER RNA; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; STAT1 PROTEIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TOSYLLYSYL CHLOROMETHYL KETONE; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; CHEMICAL STRUCTURE; CONTROLLED STUDY; DNA BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INFLAMMATION; KERATINOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN INFLAMMATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; CHEMOKINE CCL17; HUMANS; HYDROLYZABLE TANNINS; INTERFERON-GAMMA; JUGLANS; KERATINOCYTES; NF-KAPPA B; STAT1 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

JUGLANS MANDSHURICA;

EID: 67651064287     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.06.137     Document Type: Article

References (23)

1. Gröne A. Keratinocytes and cytokines. Vet. Immunol. Immunopathol. 88 (2002) 1-12
2. Sebastiani S., Albanesi C., De P.O., Puddu P., Cavani A., and Girolomoni G. The role of chemokines in allergic contact dermatitis. Arch. Dermatol. Res. 293 (2002) 552-559
3. Saeki H., and Tamaki K. Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases. J. Dermatol. Sci. 43 (2006) 75-84
4. Kakinuma T., Nakamura K., Wakugawa M., Mitsui H., Tada Y., Saeki H., Torii H., Asahina A., Onai N., Matsushima K., and Tamaki K. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J. Allergy Clin. Immunol. 107 (2001) 535-541
5. Shimada Y., Takehara K., and Sato S. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. J. Dermatol. Sci. 34 (2004) 201-208
6. Vestergaard C., Yoneyama H., Murai M., Nakamura K., Tamaki K., Terashima Y., Imai T., Yoshie O., Irimura T., Mizutani H., and Matsushima K. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J. Clin. Invest. 104 (1999) 1097-1105
7. Vestergaard C., Bang K., Gesser B., Yoneyama H., Matsushima K., and Larsen C.G. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J. Invest. Dermatol. 115 (2000) 640-646
8. Choi B.M., Kim H.J., Oh G.S., Pae H.O., Oh H., Jeong S., Kwon T.O., Kim Y.M., and Chung H.T. 1,2,3,4,6-Penta-O-galloyl-beta-d-glucose protects rat neuronal cells (Neuro 2A) from hydrogen peroxide-mediated cell death via the induction of heme oxygenase-1. Neurosci. Lett. 328 (2002) 185-189
9. Ho L.L., Chen W.J., Lin-Shiau S.Y., and Lin J.K. Penta-O-galloyl-beta-d-glucose inhibits the invasion of mouse melanoma by suppressing metalloproteinase-9 through down-regulation of activator protein-1. Eur. J. Pharmacol. 453 (2002) 149-158
10. Kang D.G., Moon M.K., Choi D.H., Lee J.K., Kwon T.O., and Lee H.S. Vasodilatory and anti-inflammatory effects of the 1,2,3,4,6-penta-O-galloyl-beta-d-glucose (PGG) via a nitric oxide-cGMP pathway. Eur. J. Pharmacol. 524 (2005) 111-119
11. Lee S.J., Lee H.K., Jung M.K., and Mar W. In vitro antiviral activity of 1,2,3,4,6-penta-O-galloyl-beta-d-glucose against hepatitis B virus. Biol. Pharm. Bull. 29 (2006) 2131-2134
12. Oh G.S., Pae H.O., Choi B.M., Lee H.S., Kim I.K., Yun Y.G., Kim J.D., and Chung H.T. Penta-O-galloyl-beta-d-glucose inhibits phorbol myristate acetate-induced interleukin-8 gene expression in human monocytic U937 cells through its inactivation of nuclear factor-kappaB. Int. Immunopharmacol. 4 (2004) 377-386
13. Lee S.J., Lee I.S., and Mar W. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 activity by 1,2,3,4,6-penta-O-galloyl-beta-d-glucose in murine macrophage cells. Arch. Pharm. Res. 26 (2003) 832-839
14. Song H.Y., Lee J.A., Ju S.M., Yoo K.Y., Won M.H., Kwon H.J., Eum W.S., Jang S.H., Choi S.Y., and Park J. Topical transduction of superoxide dismutase mediated by HIV-1 Tat protein transduction domain ameliorates 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in mice. Biochem. Pharmacol. 75 (2008) 1348-1357
15. Nishizawa N., Yamagishi T., Nonaka G., and Nishioka I. Tannins and related compounds, part 5. Isolation and characterization of polygalloylglucoses from Chinese gallotannin. J. Chem. Soc. Perkin. Trans. 1 (1982) 2963-2968
16. Kashiwada Y., Nonaka G., and Nishioka I. Tannins and related compounds. XXIII. Rhubarb (4): isolation and structures of new classes of gallotannins. Chem. Pharm. Bull. 32 9 (1984) 3461-3470
17. Vestergaard C., Kirstejn N., Gesser B., Mortensen J.T., Matsushima K., and Larsen C.G. IL-10 augments the IFN-gamma and TNF-alpha induced TARC production in HaCaT cells: a possible mechanism in the inflammatory reaction of atopic dermatitis. J. Dermatol. Sci. 26 (2001) 46-54
18. Zheng X., Nakamura K., Tojo M., Oyama N., Nishibu A., Satoh M., Kakinuma T., Wakugawa M., Tamaki K., and Kaneko F. TGF-beta1-mediated regulation of thymus and activation-regulated chemokine (TARC/CCL17) synthesis and secretion by HaCaT cells co-stimulated with TNF-alpha and IFN-gamma. J. Dermatol. Sci. 30 (2002) 154-160
19. Darnell Jr. J.E., Kerr I.M., and Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264 (1994) 1415-1421
20. Dhar A., Young M.R., and Colburn N.H. The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive. Mol. Cell. Biochem. 234-235 (2002) 185-193
21. Kanda N., Shimizu T., Tada Y., and Watanabe S. IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes. Eur. J. Immunol. 37 (2007) 338-350
22. Kanda N., and Watanabe S. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes. Endocrinology 148 (2007) 2317-2325
23. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3 (2003) 745-756